| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Ocular Therapeutix, Inc.: Ocular Therapeutix To Present at Two Ophthalmology Meetings, May 4-9, 2024 | 6 | GlobeNewswire (USA) | ||
| Mi | Ocular Therapeutix, Inc.: Ocular Therapeutix to Host Investor Day in New York City on Thursday, June 13, 2024 | 15 | GlobeNewswire (USA) | ||
| 20.04. | Baird sees weakness in Ocular shares as "overdone" | 3 | Seeking Alpha | ||
| 18.04. | OCULAR THERAPEUTIX, INC - 8-K, Current Report | 37 | SEC Filings | ||
| 18.04. | Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder | 37 | Benzinga.com | ||
| 18.04. | Ocular Therapeutix Reports Positive Phase 1 Data For Axpaxli In NPDR | 30 | RTTNews | ||
| 18.04. | Ocular marks early-stage trial win for diabetic retinopathy candidate | 1 | Seeking Alpha | ||
| 18.04. | Ocular Therapeutix, Inc.: Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathy | 352 | GlobeNewswire (Europe) | 46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0% in the control arm No patients in the AXPAXLI... ► Artikel lesen | |
| 16.04. | The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts | 17 | Benzinga.com | ||
| 15.04. | Ocular Therapeutix CEO Mattessich To Step Down, Dugel To Succeed | 4 | RTTNews | ||
| 15.04. | Ocular Therapeutix names its chair Dugel as new CEO | 1 | Seeking Alpha | ||
| 09.04. | Advanced therapy CDMO Ascend nabs Florida manufacturing site and team from ocular gene therapy outfit Beacon | 2 | FiercePharma | ||
| 09.04. | Ocular Therapeutix, Inc.: Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics | 114 | GlobeNewswire (Europe) | BEDFORD, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular"), a biopharmaceutical company committed to enhancing people's vision and quality of life through... ► Artikel lesen | |
| 06.04. | Ocular Therapeutix, Inc.: Ocular Therapeutix Announces Positive Phase 2 PAXTRAVA Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting | 19 | GlobeNewswire (USA) | ||
| 29.03. | OCULAR THERAPEUTIX, INC - 8-K, Current Report | 6 | SEC Filings | ||
| 26.03. | Ocular Therapeutix, Inc.: Ocular Therapeutix To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery) | 4 | GlobeNewswire (USA) | ||
| 26.03. | Ocular Therapeutix files to sell 43.22M shares of common stock for holders | 5 | Seeking Alpha | ||
| 22.03. | OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 | 256 | GlobeNewswire (Europe) | Ocular Pain Relief showed statistically significant improvement as early as day 15 and the benefit was durable throughout the trial.Conjunctival Staining improved as early as day 29 with a durable benefit... ► Artikel lesen | |
| 13.03. | Decoding 6 Analyst Evaluations For Ocular Therapeutix | 13 | Benzinga.com | ||
| 12.03. | These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 Results | 5 | Benzinga.com |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.831 |
| NEL | 1.637 |
| APPLE | 1.521 |
| BAYER | 1.490 |
| BYD | 1.478 |
| SUPER MICRO COMPUTER | 1.356 |
| DEUTSCHE BANK | 1.241 |
| NVIDIA | 1.219 |
| TUI | 1.219 |
| PLUG POWER | 1.075 |
| TESLA | 1.026 |
| DAIMLER TRUCK | 935 |
| MERCEDES-BENZ | 913 |
| RHEINMETALL | 895 |
| RWE | 891 |
| AURUBIS | 806 |
| RENK GROUP | 782 |
| DEUTSCHE LUFTHANSA | 781 |
| COMMERZBANK | 761 |
| VOLKSWAGEN | 759 |
| AMAZON | 752 |
| SIEMENS ENERGY | 692 |
| AIXTRON SE | 669 |
| SIXT SE VZ | 651 |
| ALLIANZ | 617 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
